{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:38:54Z","timestamp":1792273134531,"version":"4.4.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"\n Background and purpose:<\/jats:title>\n Prolonging the drug release can be a suitable approach to overcome the challenges related to topical ophthalmic administration of drugs especially the ones prescribed for chronic ailments. The sustained delivery of the drug would reduce the required frequency of administration which could extremely improve patient compliance and feeling of well-being. This study aimed to develop nanofibrous inserts for sustained ophthalmic delivery of timolol maleate (TIM) for the treatment of glaucoma.<\/jats:p>\n <\/jats:sec>\n \n Experimental approach:<\/jats:title>\n \n Polycaprolactone-based nanofibers containing TIM were prepared using pure polycaprolactone or a blend of it with cellulose acetate or Eudragit RL100 polymers by the electrospinning method. Following the preparation, polymeric inserts were evaluated for morphological and physicochemical properties. The\n in vitro<\/jats:italic>\n drug release was assessed and the\n in vivo<\/jats:italic>\n efficacy of a selected insert in decreasing the intraocular pressure (IOP) was also evaluated in the equine eyes.\n <\/jats:p>\n <\/jats:sec>\n \n Findings \/ Results:<\/jats:title>\n \n Prepared nanofibers indicated diameter ranged between 122-174 nm. The formulations showed suitable physicochemical properties and stability for ophthalmic administration.\n In vitro<\/jats:italic>\n release study showed prolonged release of drug during more than 3 days.\n In vivo<\/jats:italic>\n evaluation revealed that the prepared insert is non-irritant and non-toxic to the equine eyes while having suitable efficacy in decreasing the IOP during 6 days.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and implication:<\/jats:title>\n Prepared TIM inserts indicated a higher efficacy than commercial TIM eye drop in lowering IOP during a prolonged period. Thus, these formulations can be considered suitable for enhancing patient compliance by reducing the frequency of administration in the treatment of glaucoma.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/1735-5362.355196","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T07:09:29Z","timestamp":1661843369000},"page":"468-481","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Development and evaluation of polycaprolactone-based electrospun nanofibers containing timolol maleate as a sustained-release device for treatment of glaucoma"],"prefix":"10.4103","volume":"17","author":[{"given":"Shahla","family":"Mirzaeei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Bahrami","family":"Faryadras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Mehrandish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Daneshgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Karami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20240909","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pharmaceutics4010197","article-title":"Ocular drug delivery for glaucoma management","volume":"4","author":"Gooch","year":"2012","journal-title":"Pharmaceutics"},{"key":"R3-2-20240909","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","article-title":"Barriers to glaucoma drug delivery","volume":"17","author":"Ghate","year":"2008","journal-title":"J Glaucoma"},{"key":"R5-2-20240909","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1167\/iovs.13-11878","article-title":"Tear film breakup and structure studied by simultaneous video recording of fluorescence and tear film lipid layer images","volume":"54","author":"King-Smith","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-2-20240909","first-page":"1541","article-title":"Basics of ocular drug delivery systems","volume":"2","author":"Tangri","year":"2011","journal-title":"Int J Res Pharm Biomed Sci"},{"key":"R8-2-20240909","first-page":"93","article-title":"Design of novel nanoemulsion formulations for topical ocular delivery of itraconazole: development, characterization and in vitro bioassay","volume":"12","author":"Mehrandish","year":"2021","journal-title":"Adv Pharm Bull"},{"key":"R9-2-20240909","doi-asserted-by":"crossref","first-page":"28","DOI":"10.34172\/apb.2021.003","article-title":"A review on ocular novel drug delivery systems of antifungal drugs: functional evaluation and comparison of conventional and novel dosage forms","volume":"11","author":"Mehrandish","year":"2020","journal-title":"Adv Pharm Bull"},{"key":"R10-2-20240909","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/02713683.2011.652286","article-title":"Advances in ocular drug delivery","volume":"37","author":"Rawas-Qalaji","year":"2012","journal-title":"Curr Eye Res"},{"key":"R11-2-20240909","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/nnm-2018-0297","article-title":"Noninvasive biodegradable nanoparticles-in-nanofibers single-dose ocular insert: in vitro, ex vivo and in vivo evaluation","volume":"14","author":"Khalil","year":"2019","journal-title":"Nanomedicine (Lond)"},{"key":"R12-2-20240909","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/02713683.2018.1563196","article-title":"Development of nanofibrous ocular insert for retinal delivery of fluocinolone acetonide","volume":"44","author":"Singla","year":"2019","journal-title":"Curr Eye Res"},{"key":"R13-2-20240909","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0378-5173(99)00423-8","article-title":"Solubilization of timolol maleate in reversed micellar systems: measurement of particle size using SAXS and PCS","volume":"196","author":"Mackeben","year":"2000","journal-title":"Int J Pharm"},{"key":"R14-2-20240909","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2010.06.045","article-title":"Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers","volume":"397","author":"Natu","year":"2010","journal-title":"Int J Pharm"},{"key":"R15-2-20240909","first-page":"179","article-title":"A review of ropinirole prolonged release in Parkinson's disease","volume":"4","author":"Nashatizadeh","year":"2009","journal-title":"Clin Interv Aging"},{"key":"R16-2-20240909","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2013.11.016","article-title":"Development and characterization of nano-fiber patch for the treatment of glaucoma","volume":"53","author":"Gagandeep, Garg","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"R17-2-20240909","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijpharm.2017.09.029","article-title":"Development and characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers","volume":"532","author":"Mehta","year":"2017","journal-title":"Int J Pharm"},{"key":"R18-2-20240909","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/1735-5362.305193","article-title":"Development and characterization of a nano-drug delivery system containing vasaka phospholipid complex to improve bioavailability using quality by design approach","volume":"16","author":"Nandhini","year":"2021","journal-title":"Res Pharm Sci"},{"key":"R19-2-20240909","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1735-5362.305184","article-title":"Preparation and characterization of ethylcellulose microspheres for sustained-release of pregabalin","volume":"16","author":"Yasin","year":"2021","journal-title":"Res Pharm Sci"},{"key":"R20-2-20240909","first-page":"213","article-title":"Preparation and pharmaceutical evaluation of glibenclamide slow release mucoadhesive buccal film","volume":"9","author":"Bahri-Najafi","year":"2014","journal-title":"Res Pharm Sci"},{"key":"R21-2-20240909","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4103\/1735-5362.319574","article-title":"Preparation and characterization of Eudragit L 100-55\/chitosan enteric nanoparticles containing omeprazole using general factorial design: in vitro\/in vivo study","volume":"16","author":"Rezazadeh","year":"2021","journal-title":"Res Pharm Sci"},{"key":"R22-2-20240909","first-page":"432","article-title":"Formulation of tolmetin ocuserts as carriers for ocular drug delivery system","volume":"16","author":"Tofighia","year":"2017","journal-title":"Iran J Pharm Res"},{"key":"R23-2-20240909","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.msec.2008.10.037","article-title":"Effect of electrospinning parameters on the nanofiber diameter and length","volume":"29","author":"Beachley","year":"2009","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"R24-2-20240909","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msec.2019.110077","article-title":"Characterizations and application of CA\/ZnO\/AgNP composite nanofibers for sustained antibacterial properties","volume":"105","author":"Jatoi","year":"2019","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"R26-2-20240909","first-page":"341","article-title":"Factors influencing the drug release from calcium phosphate cements","volume":"7","author":"Fosca","year":"2022","journal-title":"Bioact Mater"},{"key":"R27-2-20240909","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1167\/iovs.16-20757","article-title":"Development of a \u03949-tetrahydrocannabinol amino acid-dicarboxylate prodrug with improved ocular bioavailability","volume":"58","author":"Adelli","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-2-20240909","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.matlet.2014.11.044","article-title":"Polycaprolactone nanofibers for the controlled release of tetracycline hydrochloride","volume":"141","author":"Karuppuswamy","year":"2015","journal-title":"Mater Lett"},{"key":"R29-2-20240909","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1208\/s12249-011-9701-3","article-title":"Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro\/in vivo evaluation","volume":"12","author":"Aburahma","year":"2011","journal-title":"AAPS Pharm Sci Tech"},{"key":"R30-2-20240909","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12668-019-00627-x","article-title":"Albendazole electrospun nanofiber films: in-vitro and ex-vivo assessment","volume":"9","author":"Kamble","year":"2019","journal-title":"BioNanoScience"},{"key":"R31-2-20240909","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijbiomac.2018.11.224","article-title":"Hyperbranched cellulose polyester of oral thin film and nanofiber for rapid release of donepezil; preparation and in vivo evaluation","volume":"124","author":"AnjiReddy","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"R32-2-20240909","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1515\/polyeng-2014-0352","article-title":"Enhanced delivery of diclofenac diethylamine loaded Eudragit RL 100\u00ae transdermal system against inflammation","volume":"35","author":"Ali","year":"2015","journal-title":"J Polym Eng"},{"key":"R33-2-20240909","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jmbbm.2016.09.004","article-title":"Relationships between mechanical properties and drug release from electrospun fibers of PCL and PLGA blends","volume":"65","author":"Chou","year":"2017","journal-title":"J Mech Behav Biomed Mater"},{"key":"R34-2-20240909","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/pen.21090","article-title":"Cocontinuous cellulose acetate\/polyurethane composite nanofiber fabricated through electrospinning","volume":"48","author":"Tang","year":"2008","journal-title":"Polym Eng Sci"},{"key":"R35-2-20240909","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jddst.2018.01.016","article-title":"Tetrahydro curcumin loaded PCL-PEG electrospun transdermal nanofiber patch: preparation, characterization, and in vitro diffusion evaluations","volume":"44","author":"Ravikumar","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"R36-2-20240909","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1021\/acsbiomaterials.7b00706","article-title":"Self-assembling peptide nanofiber hydrogels for controlled ocular delivery of timolol maleate","volume":"3","author":"Karavasili","year":"2017","journal-title":"ACS Biomater Sci Eng"},{"key":"R37-2-20240909","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10837450.2021.2018609","article-title":"Preparation and functional evaluation of electrospun polymeric nanofibers as a new system for sustained topical ocular delivery of itraconazole","volume":"27","author":"Mehrandish","year":"2022","journal-title":"Pharm Dev Technol"},{"key":"R38-2-20240909","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2013.11.043","article-title":"Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits","volume":"461","author":"Mishra","year":"2014","journal-title":"Int J Pharm"},{"key":"R39-2-20240909","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1023\/A:1018938310628","article-title":"Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans","volume":"11","author":"Urtti","year":"1994","journal-title":"Pharm Res"}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1735-5362.355196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:11:20Z","timestamp":1787757080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1735-5362.355196"}},"subtitle":["in vivo evaluation in equine eye"],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/1735-5362.355196","relation":{},"ISSN":["1735-5362"],"issn-type":[{"value":"1735-5362","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}